Cargando…

Microparticles as Biomarkers of Blood Coagulation in Cancer

Cancer is associated with hypercoagulopathy and increased risk of thrombosis. This negatively influences patient morbidity and mortality. Cancer is also frequently complicated by the development of venous thromboembolism (VTE). Tumor-derived tissue factor (TF)-bearing microparticles (MPs) are associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nomura, Shosaku, Niki, Maiko, Nisizawa, Tohru, Tamaki, Takeshi, Shimizu, Michiomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592056/ https://www.ncbi.nlm.nih.gov/pubmed/26462252 http://dx.doi.org/10.4137/BIC.S30347

Ejemplares similares

Clinical significance of procoagulant microparticles
por: Nomura, Shosaku, et al.
Publicado: (2015)

Examination of biomarker expressions in sepsis-related DIC patients
por: Shimizu, Michiomi, et al.
Publicado: (2018)

Platelet-Derived Microparticles are an Important Biomarker in Patients with Cancer-Associated Thrombosis
por: Yamanaka, Yuta, et al.
Publicado: (2019)

Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricema
por: Nishizawa, Tohru, et al.
Publicado: (2015)

New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer
por: Niki, Maiko, et al.
Publicado: (2017)

Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients
por: Sawai, Yusuke, et al.
Publicado: (2020)

A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis
por: Ishii, Nobuyasu, et al.
Publicado: (2021)

Microparticles and a P-Selectin-Mediated Pathway of Blood Coagulation
por: Celi, Alessandro, et al.
Publicado: (2004)

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer
por: SHIMIZU, TOSHIKI, et al.
Publicado: (2013)

Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non-tuberculous mycobacteria: A case report and review of the literature
por: INAGAKI, NORIKO, et al.
Publicado: (2013)

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
por: Omoto, Seitaro, et al.
Publicado: (2015)

Microparticle Phosphatidylserine Mediates Coagulation: Involvement in Tumor Progression and Metastasis
por: Jing, Haijiao, et al.
Publicado: (2023)

Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation
por: Nomura, Shosaku, et al.
Publicado: (2023)

Nail alterations as a surrogate marker for the efficacy of low-dose metronomic chemotherapy
por: KIBATA, KAYOKO, et al.
Publicado: (2013)

Preliminary study of microparticle coagulation properties in septic patients with disseminated intravascular coagulation
por: Meng, Shishuai, et al.
Publicado: (2021)

Erythrocyte-Derived Microparticles Supporting Activated Protein C-Mediated Regulation of Blood Coagulation
por: Livaja Koshiar, Ruzica, et al.
Publicado: (2014)

Six cases of autoimmune acquired coagulation factor VIII deficiency: Single center experience in Japan
por: Konishi, Akiko, et al.
Publicado: (2020)

Corrigendum to “Preliminary study of microparticle coagulation properties in septic patients with disseminated intravascular coagulation”
Publicado: (2022)

Impact of Endothelial Microparticles on Coagulation, Inflammation, and Angiogenesis in Age-Related Vascular Diseases
por: Markiewicz, Margaret, et al.
Publicado: (2013)

Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports
por: Ito, Tomoki, et al.
Publicado: (2014)

Efficacy of gefapixant, a P2X(3) antagonist, for lung cancer-related cough: a case report
por: Ishiura, Yoshihisa, et al.
Publicado: (2023)

Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus
por: Nomura, Shosaku, et al.
Publicado: (2011)

Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer
por: Niki, Maiko, et al.
Publicado: (2018)

Assessment of soluble cytotoxic T lymphocyte-associated antigen-4, transforming growth factor β(1), and platelet-derived microparticles during dasatinib therapy for patients with chronic myelogenous leukemia
por: Nomura, Shosaku, et al.
Publicado: (2018)

Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer
por: Haghbeen, Marzieh, et al.
Publicado: (2021)

Microparticles as Potential Biomarkers of Cardiovascular Disease
por: França, Carolina Nunes, et al.
Publicado: (2015)

Circulating Microparticles and Coagulation Profiles in Patients with Advanced Stage Solid Tumors
por: Sun, Der Sheng, et al.
Publicado: (2018)

Microparticle-associated tissue factor activity in dogs with disseminated intravascular coagulation
por: KOBAYASHI, Kosuke, et al.
Publicado: (2019)

Enhanced Expression of Cell-Specific Surface Antigens on Endothelial Microparticles in Sepsis-Induced Disseminated Intravascular Coagulation
por: Matsumoto, Hisatake, et al.
Publicado: (2015)

Effect of triple therapy in patients with asthma-COPD overlap
por: Ishiura, Yoshihisa, et al.
Publicado: (2019)

Localized lymphadenopathy with myelodysplastic syndrome associated with tuberculosis
por: Nakaya, Aya, et al.
Publicado: (2019)

Efficacy of Gefapixant, a P2X(3) Antagonist, for Refractory Atopic Cough
por: Ishiura, Yoshihisa, et al.
Publicado: (2023)

Advances in Diagnosis and Treatments for Immune Thrombocytopenia
por: Nomura, Shosaku
Publicado: (2016)

Characterizing blood microparticles: Technical aspects and challenges
por: Shet, Arun S
Publicado: (2008)

BLOOD COAGULATION AND THROMBOSIS
Publicado: (1955)

Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers
por: Zahran, Asmaa M, et al.
Publicado: (2019)

P1015: THE EFFECT OF THERAPY ON THE COAGULATION ACTIVITY OF MICROPARTICLES IN PATIENTS WITH PRIMARY MYELOFIBROSIS
por: Silina, Natalia, et al.
Publicado: (2023)

Endothelial Microparticles in Uremia: Biomarkers and Potential Therapeutic Targets
por: Favretto, Giane, et al.
Publicado: (2019)

Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab
por: Nakaya, Aya, et al.
Publicado: (2018)

Protein Biomarkers in Blood Reflect the Interrelationships Between Stroke Outcome, Inflammation, Coagulation, Adhesion, Senescence and Cancer
por: Fuellen, Georg, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n0bqvpeo2gp1b2tqn40gjqk5i4